Executive Medical Director, Oncology Early Development

Job overview

The Executive Medical Director, Oncology Early Development position is listed in North Chicago, IL, and is onsite. Compensation is not specified. The role supports AbbVie’s clinical development programs and its mission to deliver medicines and solutions for serious health issues, including oncology. The director leads the planning, execution, and interpretation of clinical trials and research activities for oncology development programs. The role guides cross-functional teams and clinical study integrity, translating medical and scientific evidence into high-quality data and development strategy while meeting regulatory and quality requirements.

What you'll do

• Lead design and implementation of clinical development programs
• lead clinical study teams and monitor study integrity
• review and communicate accumulating safety and efficacy data
• oversee study enrollment and timelines with Clinical Operations
• own scientific content for protocols, investigator brochures, clinical study reports, and regulatory submissions
• contribute to clinical strategy and cross-functional planning
• serve as an in-house clinical expert
• support regulatory discussions and ensure adherence to Good Clinical Practices and pharmacovigilance standards.

What we're looking for

Skills & competencies

executive medical director

oncology early development

full-time

north chicago il

abbvie

clinical trials

oncology

clinical development

medical doctor

clinical strategy

regulatory compliance

good clinical practices

Work arrangement

• Weekend coverage required

Benefits & perks

• Paid time off
• medical, dental, and vision insurance for eligible employees
• 401(k)
• eligibility to participate in long-term incentive programs.

Why this role

May oversee Medical or Scientific Directors; may serve on or chair Clinical Strategy Teams; may represent AbbVie at external meetings.

About the employer

AbbVie is hiring for this role. Industry: Research and Development in Biotechnology (except Nanobiotechnology). Sector: 54.